The Interaction between Price Negotiations and Heterogeneity: Implications for Economic Evaluations

Area of Science:

• Health Economics
• Pharmacoeconomics
• Health Technology Assessment

Background:

• Economic evaluation is crucial for drug reimbursement decisions.
• Patient heterogeneity influences clinical and economic outcomes.
• The interplay between price negotiations and population heterogeneity is understudied.

Purpose of the Study:

• To introduce a novel framework, the "hybrid approach," for economic assessments.
• To account for the interaction between drug price negotiations and population heterogeneity.
• To improve the accuracy of cost-effectiveness analyses for drug reimbursement.

Main Methods:

• Development of a "hybrid approach" framework for economic evaluations.
• Analysis of conditional drug discounts dependent on reimbursement across subgroups.
• Application of the framework through two worked examples.

Main Results:

• Failure to account for negotiation-heterogeneity interactions leads to inaccurate cost-effectiveness conclusions.
• The hybrid approach can reduce incremental cost-effectiveness ratios and increase reimbursement probability.
• Strategic pricing behaviors could potentially increase drug reimbursement prices.

Conclusions:

• The hybrid approach enhances the identification of cost-effective interventions.
• Recognizing negotiation-heterogeneity interactions may influence pharmaceutical pricing strategies.
• This research is expected to significantly impact medical decision-making and drug reimbursement policies.